[go: up one dir, main page]

WO2012134252A3 - Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis - Google Patents

Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis Download PDF

Info

Publication number
WO2012134252A3
WO2012134252A3 PCT/KR2012/002469 KR2012002469W WO2012134252A3 WO 2012134252 A3 WO2012134252 A3 WO 2012134252A3 KR 2012002469 W KR2012002469 W KR 2012002469W WO 2012134252 A3 WO2012134252 A3 WO 2012134252A3
Authority
WO
WIPO (PCT)
Prior art keywords
renal cancer
semen extract
composition
cancer treatment
functional food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/002469
Other languages
English (en)
Korean (ko)
Other versions
WO2012134252A2 (fr
Inventor
황성연
정경채
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA BIO MEDICAL SCIENCE INSTITUTE
Original Assignee
KOREA BIO MEDICAL SCIENCE INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA BIO MEDICAL SCIENCE INSTITUTE filed Critical KOREA BIO MEDICAL SCIENCE INSTITUTE
Publication of WO2012134252A2 publication Critical patent/WO2012134252A2/fr
Publication of WO2012134252A3 publication Critical patent/WO2012134252A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/14—Extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une nouvelle utilisation d'un extrait de semence de cannabis, et plus particulièrement, une composition pour le traitement du cancer du rein et un aliment fonctionnel contenant, comme ingrédient actif, un extrait de semence de cannabis ayant d'excellents effets prophylactiques et thérapeutiques sur le cancer du rein. L'extrait de semence de cannabis, selon la présente invention, élimine la prolifération des cellules cancéreuses du rein et induit leur apoptose, et peut ainsi être utilisé efficacement dans la prophylaxie et le traitement du cancer du rein.
PCT/KR2012/002469 2011-03-31 2012-04-02 Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis Ceased WO2012134252A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110029445A KR20120111125A (ko) 2011-03-31 2011-03-31 마자인 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품
KR10-2011-0029445 2011-03-31

Publications (2)

Publication Number Publication Date
WO2012134252A2 WO2012134252A2 (fr) 2012-10-04
WO2012134252A3 true WO2012134252A3 (fr) 2013-03-07

Family

ID=46932193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/002469 Ceased WO2012134252A2 (fr) 2011-03-31 2012-04-02 Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis

Country Status (2)

Country Link
KR (1) KR20120111125A (fr)
WO (1) WO2012134252A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102269816B1 (ko) * 2021-01-19 2021-06-28 주식회사 네이처센스 대마 추출물을 유효성분으로 포함하는 항암, 항암 부작용 저하 및 암 전이 억제용 조성물
KR102559079B1 (ko) * 2021-08-06 2023-07-24 이재형 한약재 복합 추출물을 유효 성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
WO2023013963A1 (fr) * 2021-08-06 2023-02-09 이재형 Composition pharmaceutique comprenant un extrait d'herbe médicinale composite en tant que principe actif pour la prévention ou le traitement du cancer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990070229A (ko) * 1998-02-18 1999-09-15 송시훈 종자유 제조방법
JP2008514687A (ja) * 2004-10-01 2008-05-08 ジーダブリュー ファーマ リミテッド 腫瘍細胞の移動の阻害
WO2008107878A1 (fr) * 2007-03-05 2008-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nouveaux dérivés quinonoïdes de cannabinoïdes et leur utilisation dans le traitement de malignités
JP2010524912A (ja) * 2007-04-19 2010-07-22 ジーダブリュー・ファーマ・リミテッド カンナビノイド含有植物抽出物の新規な用途

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990070229A (ko) * 1998-02-18 1999-09-15 송시훈 종자유 제조방법
JP2008514687A (ja) * 2004-10-01 2008-05-08 ジーダブリュー ファーマ リミテッド 腫瘍細胞の移動の阻害
WO2008107878A1 (fr) * 2007-03-05 2008-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nouveaux dérivés quinonoïdes de cannabinoïdes et leur utilisation dans le traitement de malignités
JP2010524912A (ja) * 2007-04-19 2010-07-22 ジーダブリュー・ファーマ・リミテッド カンナビノイド含有植物抽出物の新規な用途

Also Published As

Publication number Publication date
KR20120111125A (ko) 2012-10-10
WO2012134252A2 (fr) 2012-10-04

Similar Documents

Publication Publication Date Title
WO2012134169A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de semence de gleditsiae
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
PH12015500900B1 (en) A stabilized pemetrexed formulation
CA2873723A1 (fr) Inhibiteurs pyrrolopyrimidone et pyrrolopyridone de la tankyrase
PH12014501032A1 (en) 2-thiopyrimidinones
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
EP3067059A4 (fr) Composition pharmaceutique pour prévenir ou traiter des maladies thyroïdiennes, contenant de l'extrait de fruit de lonicera caerulea l. var. edulis comme principe actif
WO2014047653A3 (fr) Procédés et compositions pour prolonger la durée de conservation de produits végétaux
WO2012071520A3 (fr) Compositions fongicides et procédés
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
WO2012134252A3 (fr) Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2012134250A3 (fr) Composition pour le traitement du cancer du rein et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012134167A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait d'eriobotriae folium
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena
WO2012108745A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de gleditsiae semen
WO2012134251A3 (fr) Composition pour le traitement du cancer du pancréas et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012134168A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait d'herbe de lysimachia foenum-graecum
WO2012108744A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de la fleur inula
WO2012134165A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de semence de psoraleae
WO2012134164A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de flos farfarae
WO2012134163A3 (fr) Composition pour le traitement du cancer du poumon et composition pour produits cosmétiques contenant un extrait de rhizome de nardostachys
WO2012134170A3 (fr) Composition pour le traitement du cancer du poumon et composition pour des produits cosmétiques contenant un extrait de racine de rubia
WO2012099420A3 (fr) Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12765334

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12765334

Country of ref document: EP

Kind code of ref document: A2